A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns
The study from Icahn school of Medicine of
The study included 19 infants, among whom Nevisense successfully identified those who later developed atopic dermatitis (AD). Within the first year of life, eight of the nineteen infants developed AD, and their Nevisense scores at birth were significantly higher.
Conclusion from the study was 'Higher EIS scores, suggestive of impaired skin barrier, within the first week of life were significantly associated with development of AD in the first year of life.'
"These are very promising results, demonstrating the potential of Nevisense to predict atopic dermatitis. The findings are especially interesting, as we are simultaneously conducting larger studies on predicting atopic dermatitis in children," said
The abstract for the oral presentation at AAAAI can be found here: Assessing the Skin Barrier Using Electrical Impedance Spectroscopy in Newborns to
For further information please contact:
Phone. +46732069802
E-mail: pia.renaudin@scibase.com
Certified Advisor (CA):
Tel: +46 8 588 68 570
E-mail: certifiedadviser@carnegie.se
About
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
Built on more than 20 years of research at
The company has been on the Nasdaq First North Growth Market exchange since
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
|
PR draft Mt Sinai prediction of AD |
View original content:https://www.prnewswire.co.uk/news-releases/a-new-study-demonstrates-that-nevisense-can-predict-atopic-dermatitis-in-newborns-302689570.html
